Cargando…
Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection
INTRODUCTION: Treating systemic inflammation caused by SARS-COV 2 (COVID-19) has become a challenge for the clinician. Corticosteroids have been the turning point in the treatment of this disease. Preliminary data from Recovery clinical trial raises hope by showing that treatment with dexamethasone...
Autores principales: | Sarriá-Landete, Antonio J., Crespo-Matas, José A., Domínguez-Quesada, Inmaculada, Castellanos-Monedero, Jesús J., Marte-Acosta, Dinés, Arias-Arias, Ángel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752105/ https://www.ncbi.nlm.nih.gov/pubmed/36536623 http://dx.doi.org/10.1016/j.medcle.2022.02.028 |
Ejemplares similares
-
Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection
por: Sarriá-Landete, Antonio J., et al.
Publicado: (2022) -
A COMPARISON OF PULSE METHYLPREDNISOLONE TO LOW-DOSE METHYLPREDNISOLONE IN CRITICALLY-ILL PATIENTS WITH SARS-COV-2 PNEUMONIA: RETROSPECTIVE, OBSERVATIONAL STUDY
por: Bidin, F.N., et al.
Publicado: (2023) -
Is the treatment with pulses of methylprednisolone safe?
por: Bednarczuk, Tomasz, et al.
Publicado: (2013) -
Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
por: Singh Sehgal, Inderpaul, et al.
Publicado: (2014) -
Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy.
por: Park, E. A., et al.
Publicado: (2001)